p107 expression in colorectal tumours rises during carcinogenesis and falls during invasion

European Journal of Cancer

Volumn 38, Issue 14, 2002, Pages 1838-1848

  Wu, F ^a   Li, J Q ^a   Miki, H ^a   Nishioka, M ^a   Fujita, J ^a   Ohmori, M ^a   Imaida, K ^a   Kuriyama, S ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Colorectal carcinoma; Metastasis; p107 Protein; Survival

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; KI 67 ANTIGEN; PROTEIN P107;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME; VEIN DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CDC2-CDC28 KINASES; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA-LIKE PROTEIN P107;

EID: 0036710186     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00146-6     Document Type: Article

References (42)

1. Ichimura K., Hanafusa H., Takimoto H.et al. Structure of the human retinoblastoma-related p107 gene and its intragenic deletion in a B-cell lymphoma cell line. Gene. 251:2000;37-43.
2. Paggi M.G., Baldi A., Bonetto F.et al. Retinoblastoma protein family in cell cycle and cancer. a review J. Cell. Biochem. 62:1996;418-430.
3. Grana X., Garriga J., Mayol X. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene. 17:1998;3365-3383.
4. Claudio P.P., Howard C.M., Pacilio C.et al. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res. 60:2000;372-382.
5. Stiegler P., Kasten M., Giordano A. The RB family of cell cycle regulatory factors. J Cell Biochem (Suppl.). 30/31:1998;30-36.
6. kip1 in vulvar squamous cell carcinomas. Hum. Pathol. 32:2001;4-9.
7. De Luca A., Baldi A., Esposito V.et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat. Med. 3:1997;913-916.
8. Leoncini L., Bellan C., Cossu A.et al. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas. distinct mechanisms of cell growth control Clin. Cancer. Res. 5:1999;4065-4072.
9. Susini T., Baldi F., Howard C.M.et al. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. J. Clin. Oncol. 16:1998;1085-1093.
10. Massaro-Giordano M., Baldi G., De Luca A.et al. Differential expression of the retinoblastoma gene family members in choroidal melanoma. prognostic significance Clin. Cancer Res. 5:1999;1455-1458.
11. Baldi A., Esposito V., De Luca A.et al. Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/p130 in lung cancer. Clin. Cancer Res. 2:1996;1239-1245.
12. Baldi A., Esposito V., De Luca A.et al. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin. Cancer Res. 3:1997;1691-1697.
13. Cinti C., Leoncini L., Nyongo A.et al. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. Am. J. Pathol. 156:2000;751-760.
14. Landis S.H., Murray T., Bolden S.et al. Cancer statistics, 1999. CA Cancer J. Clin. 49:1999;8-31.
15. McKay J.A., Douglas J.J., Ross V.G.et al. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin. Cancer Res. 6:2000;1113-1118.
16. Paredes-Zaglul A., Kang J.J., Essig Y.P.et al. Analysis of colorectal cancer by comparative genomic hybridization. evidence for induction of the metastatic phenotype by loss of tumor suppressor genes Clin. Cancer Res. 4:1998;879-886.
17. McLeod H.L., McKay J.A., Collie-Duguid E.S.et al. Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur. J. Cancer. 36:2000;1706-1712.
18. Donnellan R., Chetty R. Cyclin E in human cancers. FASEB J. 13:1999;773-780.
19. Brechot C. Oncogenic activation of cyclin A. Curr. Opin. Genet. Dev. 3:1993;11-18.
20. Handa K., Yamakawa M., Takeda H.et al. Expression of cell cycle markers in colorectal carcinoma. superiority of cyclin A as an indicator of poor prognosis Int. J. Cancer. 84:1999;225-233.
21. Yasui W., Kuniyasu H., Yokozaki H.et al. Expression of cyclin E in colorectal adenomas and adenocarcinomas. correlation with expression of Ki-67 antigen and p53 protein Virchows Arch. 429:1996;13-19.
22. Kim J.H., Kang M.J., Park C.U.et al. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer. 85:1999;546-553.
23. Diebold J., Dopfer K., Lai M.et al. Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens. Scand. J. Gastroenterol. 29:1994;47-53.
24. Loda M., Cukor B., Tam S.W.et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:1997;231-234.
25. Dobashi Y., Shoji M., Jiang S.X.et al. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am. J. Pathol. 153:1998;963-972.
26. Johnston P.G., O'Brien M.J., Dervan P.A.et al. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum. Pathol. 20:1989;696-700.
27. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
28. Tatebe S., Ishida M., Kasagi N.et al. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas. analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling Int J Cancer. 65:1996;173-177.
29. Mooteri S., Rubin D., Leurgans S.et al. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis. Colon Rectum. 39:1996;1073-1080.
30. Paku S., Paweletz N. First steps of tumor-related angiogenesis. Lab. Invest. 65:1991;334-346.
31. Al-Mulla F., Keith W.N., Pickford I.R.et al. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer. 24:1999;306-314.
32. Gorlick R., Metzger R., Danenberg K.D.et al. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J. Clin. Oncol. 16:1998;1465-1469.
33. Kawamoto K., Onodera H., Kan S.et al. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer. 85:1999;18-25.
34. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:1998;585-593.
35. Baker S.J., Markowitz S., Fearon E.R.et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;912-915.
36. Ewen M.E., Xing Y.G., Lawrence J.B.et al. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell. 66:1991;1155-1164.
37. Takimoto H., Tsukuda K., Ichimura K.et al. Genetic alterations in the retinoblastoma protein-related p107 gene in human hematologic malignancies. Biochem. Biophys. Res. Commun. 251:1998;264-268.
38. Hurford R.K., Cobrinik D., Lee M.H.et al. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1997;1447-1463.
39. Wang S., Nath N., Adlam M.et al. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 18:1999;3501-3510.
40. Voorhoeve P.M., Hijmans E.M., Bernards R. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene. 18:1999;515-524.
41. Jang J.S., Lee S.J., Choi Y.H.et al. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease. Oncogene. 18:1999;1789-1796.
42. McDonald 3rd E.R., El-Deiry W.S. Cell cycle control as a basis for cancer drug development. Int. J. Oncol. 16:2000;871-886.